Arthrosi – Talk Bio

Actionable Insights Powered by AI

Sobi Acquires Arthrosi Therapeutics for $950M Upfront in Gout Drug Deal

22 hours ago talkbio0Tagged Acquisition, Arthrosi, Gout, pozdeutinurad, Sobi

Sobi; Arthrosi Therapeutics; acquisition; gout; pozdeutinurad; AR882